Apollo Pharma

Apollo Therapeutics is a unique portfolio biopharmaceutical company focused on translating high-quality academic research into innovative medicines. Established through a collaboration between world-leading universities (University of Cambridge, University College London, and Imperial College London) and major pharmaceutical companies, Apollo utilizes a hub-and-spoke model to develop a diverse pipeline across multiple therapeutic areas. The company identifies promising early-stage assets from its academic partners and applies industry-grade drug discovery and development expertise to advance them toward clinical proof-of-concept. Its portfolio spans various modalities, including small molecules and biologics, targeting significant unmet needs in oncology, inflammatory disorders, and metabolic diseases.